Algert Global’s Meridian Bioscience Inc VIVO Stock Holding History

Algert Global’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,085	Closed	-$501K	–	1368
2022 Q4	$501K	Hold	15,085	–	–	0.03%	803
2022 Q3	$476K	Buy	15,085 +6,605	+78%	+$214K	0.03%	820
2022 Q2	$258K	Buy	+8,480	New	+$229K	0.02%	956
2020 Q1	–	Sell	-20,820	Closed	-$203K	–	554
2019 Q4	$203K	Buy	+20,820	New	+$195K	0.06%	313
2018 Q1	–	Sell	-21,531	Closed	-$301K	–	388
2017 Q4	$301K	Buy	+21,531	New	+$315K	0.07%	257

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Algert Global's VIVO Position: Q1 2023 in Review

Algert Global sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 15,085 shares — an estimated $501K sold.

Algert Global first reported a position in VIVO in Q4 2017 and held it in 5 quarters. The position peaked at $501K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Algert Global reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Algert Global sold 15,085 Meridian Bioscience Inc shares in Q1 2023, an estimated $501K.
Algert Global first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 5 quarters.
Algert Global's Meridian Bioscience Inc position peaked at $501K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Algert Global's 13F filing for Q1 2023, filed 12 May 2023.